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Abstract 
 
Acetate serves as an uncommon carbon source for metabolic engineering of value-added 
chemicals. As a carbon source, acetate has unique advantages since it is not derived from food 
sources and can be produced as a waste by-product from many biological processes. This allows 
acetate to be an inexpensive feed source for biomanufacturing whose use would not affect food 
prices. However, use of acetate as a feed source for bioproduction is limited by its inhibitory 
effects. As such, fine chemicals, which have high value and low production demand, are preferred 
target products for bioproduction using acetate feed. 3-hydroxy acids, i.e. 3-hydroxybutyrate (3-
HB) and 3-hydroxyvalerate (3-HV), are one such example of fine chemicals. This study 
demonstrates the production of 3-HB and 3-HV in recombinant Escherichia coli, using acetate as 
a sole carbon source. Various metabolic pathways related to acetate metabolism such as; acetate 
assimilation, glyoxylate shunt, glycolytic and gluconeogenic pathways related to the 
phosphoenolpyruvate-pyruvate node, as well as global regulatory systems, were manipulated 
through targeted gene knockouts, to boost the production of 3-hydroxy acids. These genetic 
manipulations of the base 3-hydroxy acid-producing strain of E. coli resulted in the production of 
up to 1.75 g/L of 3-HB and 0.571 g/L of 3-HV (individually). 
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Chapter 1 – Introduction 
 
Organic chemical production has traditionally been performed by the petrochemical industry. 
Petrochemical operations rely on limited and non-renewable fossil fuels as a feed source. This has 
sparked interest in bio-manufacturing as a sustainable, alternative production method for organic 
chemicals (Gavrilescu & Chisti, 2005). Bio-manufacturing utilizes engineered cells, microbes, 
tissues, or free enzymes to produce commercially significant chemicals from biomass or waste 
(Yi-Heng Percival Zhang et al., 2017). Recent advancements in genetic engineering, 
bioinformatics, synthetic biology and metabolic engineering have given rise to novel strategies to 
exploit microbial fermentation processes for bio-based production of target chemicals (Nielsen & 
Keasling, 2016). Bio-based production operations rely on these biotechnological strategies to 
improve existing pathways, or develop novel pathways towards non-native chemical compounds 
(Schmidt‐Dannert, 2017).   
In order for bio-manufacturing operations to become economically viable, products that 
are difficult to produce chemically should be targeted, i.e. fuels, pharmaceuticals, polymers, and 
fine/platform chemicals. Fine chemicals are a group of complex chemicals (i.e. multiple functional 
groups, or chiral centres) with high value and limited production rates that are often used as multi-
purpose intermediates for other processes (Cybulski et al., 2001). 3-Hydroxy acids are a type of 
fine chemical defined by a hydroxyl group bonded to the beta-carbon relative to a carboxyl group. 
Additionally, 3-hydroxy acids contain a chiral centre, making them optical isomers with either (S) 
or (R) configurations. These 3-hydroxy acids are used as building blocks for production of 
antibiotics, vitamins, perfumes and pheromones (Lee & Lee, 2003).  Herein, we demonstrated 
production of 3-hydroxybutyrate (3-HB) and 3-hydroxyvalerate (3-HV) in engineered Escherichia 
coli using acetate as the sole carbon source. 3-HB and 3-HV also have applications as monomers 
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for biodegradable plastics (Srirangan et al., 2016) i.e. poly(3-hydroxybutyrate) (PHB) and poly(3-
hydroxybutyrate-co-3-hydroxyvalerate) (PHBV).  However, PHB has limited applications since, 
as a homopolymer, it has high crystallinity making it brittle and hard. PHB also has a high melting 
temperature limiting its workability (Wang et al., 2013). Incorporation of 3-HV into the copolymer 
PHBV, allows more desirable properties i.e. better impact resistance, toughness, flexibility, and 
decreased melting point (Wang et al., 2013). 
 Acetate has gained attention as an alternative, non-food related substrate for 
biomanufacturing (Huang et al., 2018).  As a common fermentative by-product, acetate has 
potential as an economical carbon source since it is often seen as a waste chemical of microbe-
based biomanufacturing. Acetate can also be sustainably produced by syngas fermentations or by 
lignocellulosic refineries (Chong et al., 2013; Munasinghe and Khanal (2010); Y-H Percival 
Zhang, 2008). E. coli can grow using acetate as a substrate by first transporting acetate into the 
cytosol by the acetate permease, ActP (encoded by actP) or the acetate/succinate symporter, SatP 
(encoded by satP) (Gimenez et al., 2003; Sá-Pessoa et al., 2013). Intracellular acetate can be 
assimilated into central metabolism as acetyl-CoA by either the Acs pathway or the AckA-Pta 
pathway as shown in Figure 1. Acetyl-CoA acts as a precursor for many natural metabolic 
pathways (Castaño-Cerezo et al., 2009), i.e. incorporated in the tricarboxylic acid (TCA) cycle via 
fusion with either glyoxylate or oxaloacetate(OAA) to form malate or citrate respectively. Acetyl-
CoA can also be used, a vital precursor for 3-HB and 3-HV biosynthesis, as shown in Figure 2.  
However, biosynthesis of 3-HV also requires non-native propionyl-CoA in addition to acetyl-CoA 
(Figure 2). Typically, 3-HV biosynthesis requires supplementation of a structurally similar carbon 
source to generate propionyl-CoA, i.e. valerate, or propionate (Doi et al., 1988; Tseng et al., 2010). 
However, by activating the dormant Sleeping beauty mutase (Sbm) operon present in E. coli, 
3 
 
propionyl-CoA can be produced independent of carbon source (Akawi et al., 2015). The Sbm 
pathway diverts succinyl-CoA from the TCA cycle to L-methylmalonyl-CoA then subsequently 
to propionyl-CoA (Figure 1). 
  Acetate has previously been used as a sole carbon source for metabolite production in E. 
coli, i.e. MNEI, succinate, itaconic acid, and propionate (Leone et al., 2015; Li et al., 2016; Noh 
et al., 2018; Kilpatrick 2017). A comparison of the results from these studies can be found below 
in Table 1. Additionally, results from previous studies demonstrating production of 3-HB and 3-
HV can be found in Table 2. However, it should be noted that until this study, acetate has not been 
used as a feedstock for the production either 3-HB or 3-HV. 
Utilizing acetate as a carbon source drastically affects the central metabolism pathway of 
E. coli by inducing the activation of the glyoxylate shunt and gluconeogenic pathways, influencing 
multiple regulator systems, and down-regulating glycolytic pathways (Oh et al., 2002). To 
determine the significance and effects of different metabolic pathways on 3-hydroxy acid 
production specific gene knockouts related to the acetate assimilation pathways, glyoxylate shunt, 
phosphoenolpyruvate (PEP)-pyruvate node, and global regulator systems, were investigated. This 
study demonstrated the production of 3-HB and 3-HV with titers up to 1.75 g/L and 0.571 g/L, 
respectively, using acetate as a sole carbon source in genetically engineered strains of E. coli.  
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Table 1: Comparison of this study with previous studies using acetate as a sole feed source for 
metabolite production in E. coli 
 
Table 2: Comparison of this study with previous studies for 3-hydroxy acid productions from 
unrelated carbon sources 
 
 
Product  Feedstock Study 
1.75 g/L 3-HB and 0.571 g/L 3-HV 20 g/L acetate This Study 
177 mg/L of MNEI 4.6 g/L acetate (Leone et al., 2015) 
7.3 g/L succinate 14.4 g/L acetate (Li et al., 2016) 
3.57 g/L itaconic acid 10 g/L acetate (Noh et al., 2018) 
 3.8 g/L propionate 20 g/L acetate (Kilpatrick 2017) 
Products  Host organism Feed Stock  Study 
1.75 g/L 3-HB and 
0.571 g/L 3-HV 
E. coli 20 g/L acetate This Study 
4.84 g/L 3-HB Arxula adeninvorans 50 g/L glucose (Biernacki 2017) 
2.1 g/L 3-HB E. coli 20 g/L glucose (Gao 2002) 
2.99 g/L 3-HB and 
2.29 g/L 3-HV 
E. coli 30 g/L glycerol (Miscevic 2018) 
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Figure 1: Schematic representation of natural and engineered pathways for acetate metabolism in 
CPC-Sbm. It should be noted that enzymes in red were investigated in this study through the 
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knockout of their coding gene. Acetyl-CoA and propionyl-CoA are shown in blue as they are 
necessary precursors for the biosynthesis of 3-HB and 3-HV.  Enzyme abbreviations: ArcA, DNA-
binding transcriptional dual regulator; Fnr, DNA-binding transcriptional dual regulator; CreB, 
DNA-binding transcriptional regulator; CreC, sensory histidine kinase; IclR, DNA-binding 
transcriptional repressor; AceK, isocitrate dehydrogenase kinase/phosphatase; AckA, acetate 
kinase; Pta, phosphate acetyltransferase; Acs, acetyl-CoA sythetase; PoxB, pyruvate oxidase; 
AceEF, pyruvate dehydrogenase; PflB, pyruvate formate lyase; PykF, pyruvate kinase; PpsA, 
phosphoenolpyruvate synthetase; SfcA, malate dehydrogenase (NAD+-requiring); MaeB, malate 
dehydrogenase (NADP+-requiring); PckA, phosphoenolpyruvate carboxykinase; Ppc, 
phosphoenolpyruvate carboxylase; Mdh, malate dehydrogenase; GltA, citrate synthase; AcnAB, 
aconitate hydratase; Icd, isocitrate dehydrogenase; SucAB, 2-ketoglutarate dehydrogenase; 
SucCD, succinyl-CoA synthetase; SdhCDAB, succinate:quinone oxidoreductase; FrdABCD, 
fumerate reductase; FumABC, fumerase; AceA,  isocitrate lyase; AceB, malate synthase; GlcB, 
malate synthase; Sbm, methylmalonyl-CoA mutase; YgfG, methylmalonyl-CoA decarboxylase; 
YgfH, propionyl-CoA:succinyl-CoA transferase. 
 
 
Figure 2: Heterologous 3-HB (A) and 3-HV (B) pathways from acetyl-CoA and propionyl-CoA 
precursors. Enzyme abbreviations: PhaA, acetoacetyl-CoA thiolase (from C. necator); BktB, ß-
ketothiolase (from C. necator); Hbd, 3-hydroxybutyryl-CoA dehydrogenase (from C. 
acetobutylicum); PhaB, acetoacetyl-CoA reductase (from C. necator); TesB, acyl-CoA 
thioesterase (from E. coli). 
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Chapter 2 - Materials and methods 
 
2.1 - Bacterial strains and plasmids 
A list of all E. coli strains, plasmids and DNA primers used in this study can be found in Table 1. 
Genomic DNA from various bacterial strains was isolated using the Blood & Tissue DNA Isolation 
Kit (Qiagen, Hilden, Germany). Standard recombinant DNA technologies were applied for 
molecular cloning (Miller, 1993). All plasmids were constructed by Gibson enzymatic assembly 
(Gibson et al., 2009). Phusion HF and Taq DNA polymerases were obtained from New England 
Biolabs (Ipswich, MA, USA). All synthesized oligonucleotides were obtained from Integrated 
DNA Technologies (Coralville, IA, USA). DNA sequencing was conducted by the Centre for 
Applied Genomics at the Hospital for Sick Children (Toronto, Canada). E. coli BW 25113 was the 
parental strain for derivation of all mutant strains in this study and E. coli DH5α was used as a host 
for molecular cloning. 
 Activation of the genomic Sbm operon to generate propionogenic (propionate-producing)  
E. coli, CPC-Sbm was described previously (Srirangan et al., 2014). Knockouts of the genes, were 
introduced into CPC-Sbm by P1 phage transduction (Miller, 1993) using the appropriate Keio 
Collection strains (The Coli Genetic Stock Center, Yale University, New Haven, CT, USA) as 
donors (Baba et al., 2006). To eliminate the co-transduced FRT-KnR-FRT cassette, the 
transductants were transformed with pCP20 (Cherepanov & Wackernagel, 1995), a temperature 
sensitive plasmid expressing a flippase (Flp) recombinase. Upon Flp-mediated excision of the KnR 
cassette, a single Flp recognition site (FRT “scar site”) was generated. Plasmid pCP20 was then 
removed by growing cells at 42°C. The genotypes of derived knockout strains were confirmed by 
colony PCR using the appropriate verification primer sets. 
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 The phaAB operon was amplified by polymerase chain reaction (PCR) using the primer set 
g-phaAB and the genomic DNA (gDNA) of wild-type Cupriavidus necator ATCC 43291 as the 
template. The amplified operon was Gibson–assembled (Note that “assembled” is used for 
subsequent appearance) with the PCR-linearized pTrc99a using the primer set g-pTrc-phaAB to 
generate pTrc-PhaAB. All genes inserted into pTrc99a vector were under the control of the Ptrc 
promoter. Plasmid pK-BktB-Hbd-TesB was previously constructed in our lab by PCR-amplifying 
bktB from C. necator ATCC 43291, hbd from Clostridium acetobutylicum ATCC 824, and tesB 
from E. coli BW 25141 using the corresponding primer sets (i.e. g-bktB, g-hbd, and g-tesB), 
followed by assembling all three PCR-amplified fragments with the PCR-linearized pK184 using 
the primer set g-pK-bktB-hbd-tesB. All genes inserted into pK184 vector were under the control 
of the Plac promoter. The two plasmids, pTrc-PhaAB and pK-BktB-Hbd-TesB, were transformed 
into the propionogenic host strain, CPC-Sbm, to generate the 3-hydroxy acid producing strain, 
P3HA31. 
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Table 3: List of E. coli strains, plasmids and DNA primers used in this study 
Name Description, relevant genotype or primer sequence (5’→3’) Reference 
E. coli host strains 
DH5α  F−, endA1, glnV44, thi-1, recA1, relA1, gyrA96, deoR, nupG φ80d lacZΔ M15, Δ(lacZYA – argF) 
U169, hsdR17(rK-mK +), λ- 
Lab stock 
MC4100 F-, [araD139]B/r, Del(argF-lac)169, λ–-, e14-, flhD5301, Δ(fruK-yeiR)725(fruA25), relA1, 
rpsL150(strR), rbsR22, Del(fimB-fimE)632(::IS1), deoC1 
(Casadaban, 1976) 
BW25141 F–, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), Δ(phoB-phoR)580, λ-, galU95, ΔuidA3::pir+, recA1, 
endA9(del-ins)::FRT, rph-1, Δ(rhaD-rhaB)568, hsdR514 
(Datsenko & Wanner, 
2000) 
BW25113 F–, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ–, rph-1, Δ(rhaD-rhaB)568, hsdR514 (Datsenko & Wanner, 
2000) 
BW∆ldhA BW25113∆ldhA null mutant (Akawi et al., 2015; 
Srirangan et al., 2013)  
CPC-Sbm BW∆ldhA, Ptrc::sbm (i.e. with the FRT -Ptrc cassette replacing the 204-bp upstream of the Sbm 
operon) 
(Akawi et al., 2015) 
P3HA31 CPC-Sbm/pTrc-PhaAB and pK-BktB-Hbd-TesB (Miscevic, 2018) 
P3HA31Δpta  pta null mutant of P3HA31 (Miscevic, 2018) 
P3HA31Δacs acs null mutant of P3HA31 This study 
P3HA31ΔaceB aceB null mutant of P3HA31 This study 
P3HA31ΔglcB glcB null mutant of P3HA31 This study 
P3HA31ΔaceBΔglcB aceB and glcB null mutant of P3HA31 This study 
P3HA31ΔiclR iclR null mutant of P3HA31 This study 
10 
 
P3HA31ΔsfcA sfcA null mutant of P3HA31 This study 
P3HA31ΔmaeB maeB null mutant of P3HA31 This study 
P3HA31ΔpckA pckA null mutant of P3HA31 This study 
P3HA31ΔppsA ppsA null mutant of P3HA31 This study 
P3HA31Δppc ppc null mutant of P3HA31 This study 
P3HA31ΔpykF pykF null mutant of P3HA31 This study 
P3HA31ΔaceF aceF null mutant of P3HA31 This study 
P3HA31ΔpflB pflB null mutant of P3HA31 This study 
P3HA31ΔarcA arcA null mutant of P3HA31 This study 
P3HA31Δfnr fnr null mutant of P3HA31 This study 
P3HA31ΔcreB creB null mutant of P3HA31 This study 
P3HA31ΔcreC creC null mutant of P3HA31 This study 
CPC-PHBV CPC-Sbm/pTrc-PhaCAB and pK-BktB (Srirangan et al., 2016) 
Plasmids 
pCP20 FLP+, λ cI857+, λ pR Rep(pSC101 ori)ts, ApR,CmR (Cherepanov & 
Wackernagel, 1995) 
pKD46 RepA101ts ori, Ap
R, araC-ParaB::gam-bet-exo (Datsenko & Wanner, 
2000) 
pKD3 R6K-γ ori, ApR, FRT-CmR-FRT (Datsenko & Wanner, 
2000) 
pTrc99a ColE1 ori Apr Ptrc (Amann et al., 1988) 
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pK184 p15A ori, KmR, Plac::lacZ’ (Jobling & Holmes, 
1990) 
pTrc-PhaAB Derived from pTrc99a, Ptrc:: phaAB (Miscevic, 2018) 
pK-BktB-Hbd-TesB Derived from pK184, Plac:: bktB:hbd:tesB (Miscevic, 2018) 
Primers 
v-ldhA GATAACGGAGATCGGGAATGATTAA; GGTTTAAAAGCGTCGATGTCCAGTA (Srirangan et al., 2013) 
v-pta GGCATGAGCGTTGACGCAATCA; CAGCTGTACGCGGTGATACTCAGG (Akawi et al., 2015) 
v-acs ACTTTTGCGTGATCTGTCGC; CTCCAGAGGTAATGTAGGGA This study 
v-aceB TTTCCGAAACGTACCTCAGC; CATTTTCGCTGCGCCCAGTT This study 
v-glcB GCAGACGCAGAGTATCGTTA; ACAACGGACGTACCGCGTTC This study 
v-iclR GGTGGAATGAGATCTTGCGA; CCGACACGCTCAACCCAGAT This study 
v-sfcA TCAGTGAGCGCAGTGTTTTA; AACCCAACCGGCAGAAAACG This study 
v-maeB TGGAGAGATATTCGCTGTGG; GACAGGCATGGTATTGCTGG This study 
v-pckA CCGTTTCGTGACAGGAATCA; AACGGGATGCTGGAGCTTGG This study 
v-ppsA CGCGAACTACCTCAGGTA AA; CGAAGAGAGCAGATTTGCGC This study 
v-ppc CGCCGAATGTAACGACAATTCC; TGCTGAAGCGATTTCGCAGC This study 
v-pykF GGACTGTAGAACTCAACGAC; GCGTTCGATGCTTCTTTGAG This study 
v-aceF TGCGTCACCACTTCGAAGTT; GGATTTCTGGGTGCAGCAAG This study 
v-pflB ATTTTGGACCGCAGTCGGTT; CGGTTCCACAGGATTCAAAG This study 
v-arcA TTGGGAACCAGTGTGCTGGT; ACTGTCGGGTCCTGAGGGAA This study 
v-fnr GTGCCAGCTTGTTCACACTT; TGGGAACGCCAGCATTGAGA This study 
v-creB CGATTGAACTGTCGGATCGT; AACGTTGCGGTGTCGATCAA This study 
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v-creC CGCTGACTCGGTATGAGTTT; TCAGCACGTTCGACAATCAC This study 
c-ptrc CCGATTCATTAATGCAGCTGG; GGTCTGTTTCCTGTGTGAAATTGTTA This study 
c-pK184 ATGACCATGATTACGAATTCG; AGCTGTTTCCTGTGTGAAATTGTTATCCG This study 
g-phaA CCGGCTCGTATAATGTGTGGATGACTGACGTTGTCATCGTATCC; 
TACCGAGCTCGAATTCCTTATTTGCGCTCGACTG 
(Miscevic, 2018) 
g-phaB TTCACACAGGAAACAGACATGACTAGCGCATTGCGT; 
GGTACCGAGCTCGAATTCCATGTCAGCCCATATGCAGGCC 
(Miscevic, 2018) 
g-phaAB CCGGCTCGTATAATGTGTGGATGACTGACGTTGTCATCGTATCC; 
ATTGTTATCCGCTCACAATTTCAGCCCATATGCAGGCCGA 
(Miscevic, 2018) 
g-bktB CACAGGAAACAGCTATGACCATGACGCGTAAGTGGTAGT; 
TAAACAGACCTCCCTTAAATTTAATTCAGATACGCTCGAAGATGG 
(Miscevic, 2018) 
g-hbd TTAAATTTAAGGGAGGTCTGTTTAATGAAAAAGGTATGTGTTATAGG; 
TAACAAAGCTGCCGCAGTTATTTTGAATAATCGTAGAAACCTTT 
(Miscevic, 2018) 
g-tesB GCTTTGTTACTGGAGAGTTATATGAGTCAGGCGCTAAAAA; 
GAGCTCGAATTCGTAATCATTAATTGTGATTACGCATCAC 
(Miscevic, 2018) 
g-pTrc-phaAB GCGGCCTGCATATGGGCTGATGGAATTCGAGCTCGGTACC; 
ACGATGACAACGTCAGTCATGTCTGTTTCCTGTGTGAAATTGTTATCCG 
(Miscevic, 2018) 
g-pK-bktB-hbd-tesB GGTGATGCGTAATCACAATTAATGATTACGAATTCGAGCTCGG; 
TACCACTTCACGCGTCATGGTCATAGCTGTTTCCTGTGTGAA 
(Miscevic, 2018) 
 
Notation for primers: v- verification primer, c- cloning primer, and g-Gibson DNA assembly primer. Homology arms are in bold 
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2.2 - Media and cultivations 
All medium components were obtained from Sigma-Aldrich Co. (St Louis, MO, USA) except 
yeast extract, and tryptone, which were obtained from BD Diagnostic Systems (Franklin Lakes, 
NJ, USA). The media were supplemented with antibiotics as required: 25 µg/mL kanamycin and 
50 µg/mL ampicillin. E. coli strains, stored as glycerol stocks at -80 °C, were streaked on lysogeny 
broth (LB) agar plates with appropriate antibiotics and incubated at 37°C for 14-16 h. Single 
colonies were picked from LB plates to inoculate 30-mL LB medium (10 g/L tryptone, 5 g/L yeast 
extract, and 5 g/L NaCl) with appropriate antibiotics in 125-mL conical flasks. The cultures were 
shaken at 37°C and 280 rpm in a rotary shaker (New Brunswick Scientific, NJ, USA) and used as 
seed cultures to inoculate 200 mL LB media at 1% (v/v) with appropriate antibiotics in 1-L conical 
flasks. This second seed culture was shaken at 37°C and 280 rpm until an optical density of 0.80 
OD600 was reached. Cells were then harvested by centrifugation at 9,800 ×g and 20°C for 10 min 
and resuspended in 30-mL modified M9 production media. The suspended culture was transferred 
into three identical 125-mL screw cap plastic production flasks (10mL of culture per flask) and 
incubated at either 30°C or 37°C at 280 rpm in a rotary shaker. Unless otherwise specified, the 
modified M9 production medium contained 27.78 g/L sodium acetate (to yield 20 g/L acetate), 5 
g/L yeast extract, 10 mM NaHCO3, 1 mM MgCl2, 0.2 µM cyanocobalamin (vitamin B12), 5
th 
dilution of M9 salts mix (33.9 g/L Na2HPO4, 15 g/L KH2PO4, 5 g/L NH4Cl, 2.5 g/L NaCl
 ), 1,000th 
dilution of Trace Metal Mix A5 (2.86 g/L H3BO3, 1.81 g/L MnCl2•4H2O, 0.222 g/L ZnSO4•7H2O, 
0.39 g/L Na2MoO4•2H2O, 79 µg/L CuSO4•5H2O, 49.4 µg/L Co(NO3)2•6H2O), and supplemented 
with 0.1 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG). It should be noted this media was 
controlled to a pH of 7 prior to cultivation, by addition of 5 M H2SO4 while measuring pH with a 
benchtop pH meter. All cultivation experiments were performed in triplicate. 
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2.3 - Offline analysis and metabolite quantification 
Culture samples were appropriately diluted with 0.15 M saline solution for measuring the optical 
cell density (OD600) using a spectrophotometer (DU520, Beckman Coulter, Fullerton, CA). Cell-
free medium was collected by centrifugation of the culture sample at 10,000 ×g and filter sterilized 
for titer analysis of acetate, and various metabolites using a high-performance liquid 
chromatography (HPLC; LC-10AT, Shimadzu, Kyoto, Japan) with a refractive index detector 
(RID; RID-10A, Shimadzu, Kyoto, Japan) and a chromatographic column (Aminex HPX-87H, 
Bio-Rad Laboratories, CA, USA). The HPLC column temperature was maintained at 35 °C and 
the mobile phase was 5 mM H2SO4 (pH 2.0) running at 0.6 mL/min. The RID signal was acquired 
and processed by a data processing unit (Clarity Lite, DataApex, Prague, Czech Republic). 
2.4 – Proposed methods for industrial production of 3-hydroxy acid products 
A proposed process flow diagram for industrial biomanufacturing of 3-hydroxyacid products can 
be found below in Figure 3.  Initially a seed culture is inoculated from a microbe stock stored at 
-80˚C. Next the seed culture is used to initiate a production fermenter where the cultivation 
would be carried out to produce the desired products. The fermenter effluent must then be treated 
by separation processes to remove cells, remove contaminants, isolate and finally purify the 3-
hydroxy acid products. Initially, microbe cells would be removed from the liquid effluent by 
centrifugation and filtration (Shuler & Kargi 2002). Next the cell-free media can be subjected to 
activated carbon adsorption to remove contaminants (i.e., volatile organic carbons (VOCs) and 
heavy metals) from the media. 3-hydroxy acids can be separated from the other media 
components by a combination of extraction, distillation and/or precipitation processes (Li et al., 
2015). Extraction utilizes a solvent to dissolve the 3-hydroxy acids but is immiscible with water 
allowing distinct phases to separate the 3-hydroxy acids from the aqueous mixture. Additionally, 
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reactive extraction can be performed by performing an esterification reaction on 3-hydroxy acids 
to increase the extraction efficiency (Li et al., 2015). Distillation can be used to separate media 
components based on the volatility of the components. Distillation can be used to vaporize water 
and volatile compounds to separate them from the less volatile 3-hydroxy acids (Li et al., 2015). 
3-hydroxy acids may also be precipitated from liquid media using the addition of calcium to 
create insoluble calcium salts of 3-hydroxy acids. The solid precipitates can then be filtered from 
the liquid media (Li et al., 2015).  These methods can effectively separate 3-hydroxy acids from 
most other media components, however purification of 3-HB and 3-HV as well as enantiomeric 
separation requires further processing. Chiral chromatography using an ion-exchange column 
(i.e., Chiralpak QN-AX, and Chiralpak ZWIX(+)) can effectively isolate 3-HB and 3-HV while 
also separating (R) and (S) enantiomers of both compounds (Ianni et al., 2014). Separation of 3-
HB and 3-HV enantiomers may also be accomplished by coupled preferential crystallization 
(Chaaban et al., 2014). This process operates by passing a mixed feed stream through a pair of 
crystallization vessels. Each vessel preferentially crystalizes either (R) or (S) enantiomers 
yielding solid purified products (Chaaban et al., 2014). Finally, the purified 3-HB and 3-HV 
undergo drying to remove any residual water then packaging and distribution to the consumer. 
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 Figure 3: A process flow diagram describing the proposed process for bio-production of 3-HB 
and 3-HV. 
Chapter 3 – Results 
 
3.1 - Heterologous expression of 3-hydroxy acid pathway 
3-HB and 3-HV are non-native products from E. coli metabolism, therefore multiple genetic 
engineering strategies are required to effectively produce 3-HB and 3-HV. The physiologically 
dormant Sleeping beauty mutase (Sbm) operon was previously activated in the E. coli host strain, 
to yield the propionogenic strain, CPC-Sbm. The Sbm pathway acts on succinyl-CoA to divert 
carbon from the TCA cycle and produce propionyl-CoA, an essential precursor for odd-chain 
metabolite production, i.e. 3-HV (Akawi et al., 2015; Miscevic, 2018; Srirangan et al., 2014). The 
optimum 3-hydroxy acid producing strain, P3HA31 (Miscevic, 2018) was generated by 
heterologous expression of the 3-hydroxy acid-pathway (Figure 2) in a double plasmid system. 
The first step of the pathway consists of either the homo-fusion of 2 acetyl-CoA moieties or the 
hetero-fusion of acetyl-CoA and propionyl-CoA to form acetoacetyl-CoA or 3-ketovaleryl-CoA 
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respectively. The fusion reaction is carried out by either the β-ketothiolase, BktB, (encoded by 
bktB) or by the acetyl-CoA acetyltransferase, PhaA, (encoded by phaA). In the second step, 
acetoacetyl-CoA and 3-ketovaleryl-CoA are reduced to both (R) and (S) enantiomers of 3-
hydroxybutyryl-CoA (3-HB-CoA) and 3-hydroxyvaleryl-CoA (3-HV-CoA) respectively. The 
NADH-dependent 3-HB-CoA dehydrogenase, Hbd (encoded by hbd) catalyzes the reduction to 
specifically form (S) enantiomers, whereas the NADPH-dependent acetoacetyl-CoA reductase, 
PhaB (encoded by phaB) catalyzes the reduction to specifically form (R) enantiomers. In the final 
step of the 3-hydroxy acid pathways, 3-HB-CoA and 3-HV-CoA undergo hydrolysis via an 
enantiomerically independent thioesterase, TesB (encoded by tesB) to form both enantiomers of 
3-HB and 3-HV, respectively.  
3.2 - Manipulation of cultivation conditions 
Cultivation conditions, specifically temperature and initial carbon source concentrations, were 
explored to determine their effects on 3-hydroxy acid productions. P3HA31 was cultivated at 30˚C 
and 37˚C and the results are shown in Table 4. The 30˚C culture produced both 3-hydroxy acids 
at significantly higher titers and yields than the culture at 37˚C.  It was necessary to determine an 
appropriate concentration of acetate in the initial cultivation medium, since accumulation of 
acetate can inhibit growth and metabolite production of cell cultures (De Mey et al., 2007).  
Cultivations were performed using 10, 20, and 30 g/L of acetate as the sole carbon source in the 
media, as shown in Table 5. At 10 and 20 g/L of acetate in the media, the growth and product 
yields for P3HA31 were similar to each other. Acetate inhibition was not significant at these 
concentrations since over 90% of the initial acetate was consumed in these cultivations. However, 
when P3HA31 was cultivated at 30 g/L acetate, the growth was significantly inhibited, 3-hydroxy 
acid titers were lower than at 20 g/L acetate, and approximately 20% of the initial acetate was 
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consumed (Figure 4). These results are corroborated by previous research using acetate for 
cultivations of CPC-Sbm (Kilpatrick 2017). The researchers also observed inhibition of cell 
growth and metabolite productions at 30 g/L of acetate, whereas this inhibition was not observed 
at 20 g/L of acetate. Therefore, 20 g/L of acetate in media was favoured to enhance production of 
both 3-hydroxy acids without significantly inhibiting the cell growth or product yield.    
Table 4: Growth data and metabolite profile of P3HA31 cultivations at different temperatures. 
a 
Measured cell density after 48h cultivation using spectrophotometer (OD600) initial cell densities were kept at ~5.0 
b Consumed acetate after 48h cultivation (20 g/L initial concentration) 
c Metabolites produced after 48h cultivation, yield is presented in parentheses as a percentage of theoretical 
maximum yield based on acetate consumed (%) 
 
 
 
 
 
 
 
 
 
Temperature Cell 
density 
(OD600)a 
Acetate 
consumed 
(g/L)b 
Metabolites produced (g/L)c 
3-HB  3-HV  Propionate  
30˚C 8.99 ± 0.39 16.6 ± 0.6 0.563 ± 0.028 
(4.0%) 
0.527 ± 0.059 
(4.9%) 
2.22 ± 0.48 
(21.8%) 
37˚C  7.01 ± 0.39 15.1 ± 0.6 0.510 ± 0.047 
(3.9%) 
0.389 ± 0.022 
(3.5%) 
1.34 ± 0.07 
(14.4%) 
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Table 5: Growth data and metabolite profile of P3HA31 grown in different acetate concentrations. 
a 
Measured cell density after 48h cultivation using spectrophotometer (OD600) initial cell densities were kept at ~5.0 
b Consumed acetate after 48h cultivation  
c Metabolites produced after 48h cultivation, yield is presented in parentheses as a percentage of theoretical 
maximum yield based on acetate consumed (%) 
d No 3-HV was detected as the 3-HV peak could not be accurately separated from the acetate peak 
 
 
 
Initial acetate 
concentration 
in media (g/L) 
Cell 
density 
(OD600)a 
Acetate 
consumed 
(g/L)b 
Metabolites produced (g/L)c 
3-HB  3-HV  Propionate  
10 9.3 10 0.285 
(3.3%) 
0.249 
(3.8%) 
1.704 
(27.6%) 
20 9.39 18.3 0.562 
(3.6%) 
0.571 
(4.8%) 
2.92 
(25.9%) 
30 4.28 6.4 0.471 
(8.5%) 
N.D.d 
 
0.319  
(8.0%) 
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Figure 4: A graph comparing the percent yield of 3-hydroxy acids produced and percent of acetate 
consumed for P3HA31 cultivated with different initial acetate concentrations in the cultivation 
media.  
3.3 - Genetic manipulation of acetate assimilation pathways 
Acetate assimilation occurs via two distinct pathways: (i) acetate is converted to acetyl-phosphate 
by the acetate kinase, AckA, (encoded by ackA) then to acetyl-CoA by the phosphate 
acetyltransferase, Pta, (encoded by pta) in the AckA-Pta pathway, or (ii) acetate is directly 
converted to acetyl-CoA by the acetyl-CoA sythetase, Acs, (encoded by acs). The metabolite 
profiles and growth data for these gene knockouts is given in Table 6 and the relative 3-hydroxy 
acid productions are shown in Figure 5. In P3HA31∆pta, the AckA-Pta pathway was inactivated 
and the mutant had negligible 3-HB and 3-HV production. Despite the lack of metabolite 
production, cell growth was not significantly inhibited compared to P3HA31. The complimentary 
acetate assimilation pathway was inactivated in P3HA31Δacs, which resulted in comparable 3-
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HB titer compared to P3HA31, and negligible 3-HV production. Cell growth was not significantly 
inhibited in P3HA31Δacs compared to P3HA31. 
Table 6: Growth data and metabolite profile of P3HA31 and mutants of genes related to the acetate 
assimilation. 
a 
Measured cell density after 48h cultivation using spectrophotometer (OD600) initial cell densities were kept at ~5.0 
b Consumed acetate after 48h cultivation (20 g/L initial concentration) 
c Metabolites produced after 48h cultivation, yield is presented in parentheses as a percentage of theoretical 
maximum yield based on acetate consumed (%) 
d No 3-HV was detected as the 3-HV peak could not be accurately separated from the acetate peak 
 
 
 
Strain Cell 
density 
(OD600)a 
Acetate 
consumed 
(g/L)b 
Metabolites produced (g/L)c 
3-HB  3-HV Propionate  
P3HA31 
(control) 
9.39 ± 0.63 18.3 ± 1.6 0.562 ± 0.044 
(3.6%) 
0.571 ± 0.053 
(4.8%) 
2.92 ± 0.67 
(25.9%) 
P3HA31∆pta 9.2 ± 1.4 8.7 ± 2.4 0.073 ± 0.024 
(0.9%) 
N.D.d 
 
0.092 ± 0.019 
(1.7%) 
P3HA31∆acs 8.1 ± 0.5 6.9 ± 2.6 0.65 ± 0.07 
(11.0%) 
N.D.d 
 
0.80 ± 0.11 
(18.8%) 
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Figure 5: A graph comparing the production of 3-HB and 3-HV relative to P3HA31 for the 
mutants of genes associated with acetate assimilation. 
3.4 - Genetic manipulation of the glyoxylate shunt pathway 
The glyoxylate shunt pathway can be induced under acetate metabolism, leading to high carbon 
flux through this pathway (Oh et al., 2002). The growth data and metabolite profile for the genetic 
manipulation of the glyoxylate shunt can be found in Table 7 with the relative 3-hydroxyacid 
productions shown in Figure 6. The pathway is derived from the aceBAK operon which codes for 
the isocitrate lyase, AceA, (encoded by aceA), the malate synthase, AceB, (encoded by aceB), and 
the isocitrate dehydrogenase kinase/phosphatase, AceK, (encoded by aceK). AceA decomposes 
isocitrate to form glyoxylate and succinate. AceB fuses acetyl-CoA and glyoxylate to form malate, 
serving as a route for acetyl-CoA to enter the TCA cycle. AceK acts to phosphorylate the isocitrate 
dehydrogenase, Icd (encoded by icd), inhibiting its activity.  In P3HA31∆aceB the cell growth was 
inhibited, however the 3-HB titer for this mutant was comparable to the 3-HB titer of P3HA31. E. 
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coli possesses a second malate synthase, GlcB, (encoded by glcB), which is involved in glycolate 
and glyoxylate metabolism pathways. P3HA31∆glcB also produced comparable levels of 3-HB to 
that of the P3HA31, yet did not inhibit cell growth as significantly as P3HA31∆aceB. The double 
mutant P3HA31∆aceB∆glcB removed the activity of both malate synthases resulting in a 2.6-fold 
increase in 3-HB titer over the P3HA31, despite significantly inhibited cell growth. The activity 
of the DNA-binding transcriptional repressor for the aceBAK operon, IclR, (encoded by iclR) was 
removed in P3HA31∆iclR and lead to slight reductions in both 3-HV and 3-HB titers, compared 
to P3HA31.  P3HA31∆iclR also had slightly impaired growth compared the P3HA31.   
Table 7: Growth data and metabolite profile of P3HA31 and mutants of genes related to the 
glyoxylate shunt. 
a 
Measured cell density after 48h cultivation using spectrophotometer (OD600) initial cell densities were kept at ~5.0 
b Consumed acetate after 48h cultivation (20 g/L initial concentration) 
c Metabolites produced after 48h cultivation, yield is presented in parentheses as a percentage of theoretical 
maximum yield based on acetate consumed (%) 
d No 3-HV was detected as the 3-HV peak could not be accurately separated from the acetate peak 
Strain Cell 
density 
(OD600)a 
Acetate 
consumed 
(g/L)b 
Metabolites produced (g/L)c 
3-HB  3-HV  Propionate  
P3HA31  
(control) 
9.39 ± 0.63 18.3 ± 1.6 0.562 ± 0.044 
(3.6%) 
0.571 ± 0.053 
(4.8%) 
2.92 ± 0.67 
(25.9%) 
P3HA31∆aceB  7.38 ± 0.28 7.4 ± 1.5 0.45 ± 0.11 
(7.0%) 
N.D.d 
 
0.40 ± 0.08 
(8.8%) 
P3HA31∆glcB 8.7 ± 1.1 10.0 ± 3.0 0.74 ± 0.21 
(8.4%) 
N.D.d 
 
1.0 ± 0.8 
(16.0%) 
P3HA31∆aceB∆glcB 6.82 ± 0.33 10.0 ± 3.5 1.40 ± 0.19 
(15.8%) 
N.D.d 
 
0.49 ± 0.33 
(7.9%) 
P3HA31∆iclR 8.38 ± 0.09 7.96 ± 0.16 0.45 ± 0.05 
(6.4%) 
0.362 ± 0.002 
(6.8%) 
0.66 ± 0.09 
(13.4%) 
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Figure 6: A graph comparing the production of 3-HB and 3-HV relative to P3HA31 for the 
mutants of genes associated with the glyoxylate shunt. 
3.5 - Genetic manipulation of the pathways related to the PEP-pyruvate node 
The PEP-pyruvate node serves as a complex interchange of glycolytic and gluconeogenic 
pathways, as well as carbon exchange between these pathways and the TCA cycle.  The results of 
the gene knockouts related to the PEP-pyruvate node are given in Table 8 with the relative 3-
hydroxy acid productions shown in Figure 7. Pyruvate may be generated directly from malate by 
either of two malate dehydrogenases, SfcA, and MaeB (encoded by sfcA and maeB respectively). 
The malate dehydrogenases differ in their reducing equivalent production; SfcA is NADH-
producing while MaeB is NADPH-producing. P3HA31∆sfcA produced negligible amounts of 
either 3-hydroxy acids, whereas P3HA31∆maeB produced less 3-HB compared to P3HA31 and 
negligible amounts of 3-HV. Both P3HA31∆sfcA and P3HA31∆maeB had slightly inhibited cell 
growth compared to P3HA31. PEP can be generated from oxaloacetate (OAA) by the PEP 
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carboxykinase, PckA (encoded by pckA). The removal of PckA activity in P3HA31∆pckA did not 
significantly affect cell growth or 3-HB titer while exhibiting a slight decrease in 3-HV titer 
compared to P3HA31. PEP can be returned to the TCA cycle via the activity of Ppc (encoded by 
ppc) producing OAA. Removing the activity of Ppc in P3HA31Δppc, resulted in a significant 
decrease in 3-HB titer compared to P3HA31 and negligible 3-HV production. P3HA31Δppc did 
not significantly affect cell growth compared P3HA31. The inter-conversion of pyruvate and PEP 
are maintained by the PEP synthetase, PpsA, (encoded by ppsA) and the pyruvate kinase, PykF, 
(encoded by pykF). PykF catalyzes the conversion of PEP to pyruvate (producing ATP), whereas 
the conversion of pyruvate to PEP (requiring ATP) is catalyzed by PpsA.  P3HA31∆pykF did not 
have a significant effect on either 3-HB or 3-HV titers, and slightly inhibited cell growth compared 
to P3HA31. P3HA31ΔppsA produced approximately a 1.5-fold higher titer of 3-HB compared to 
P3HA31, while also producing negligible amounts of odd-chained metabolites (3-HV and 
propionate). Removal of PpsA activity did not significantly affect cell growth. P3HA31∆aceF 
removed the activity of AceF (encoded by aceF), a critical subunit of the aerobic pyruvate 
dehydrogenase complex (AceEF). This mutant exhibited significant growth deficiencies in LB 
media, however when cultivated in acetate media the growth was restored and OD600 exceeded 
that of P3HA31. P3HA31∆aceF also yielded a 1.9-fold increase in 3-HB titer and a significant 
decrease in 3-HV titer. Catalyzing a similar reaction, the activity of pyruvate formate lyase, PflB, 
(encoded by pflB) was removed in P3HA31∆pflB. This resulted in insignificant changes in 3-HB 
and 3-HV titers while slightly inhibiting cell growth.  
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Table 8: Growth data and metabolite profile of P3HA31 and mutants of genes related to the PEP-
pyruvate node. 
a 
Measured cell density after 48h cultivation using spectrophotometer (OD600) initial cell densities were kept at ~5.0 
b Consumed acetate after 48h cultivation (20 g/L initial concentration) 
c Metabolites produced after 48h cultivation, yield is presented in parentheses as a percentage of theoretical 
maximum yield based on acetate consumed (%) 
d No 3-HV was detected as the 3-HV peak could not be accurately separated from the acetate peak 
Strain Cell density 
(OD600)a 
Acetate 
consumed 
(g/L)b 
Metabolites produced (g/L)c 
3-HB  3-HV  Propionate 
P3HA31  
(control) 
9.39 ± 0.63 18.3 ± 1.6 0.562 ± 0.044 
(3.6%) 
0.571 ± 0.053 
(4.8%) 
2.92 ± 0.67 
(25.9%) 
P3HA31∆sfcA 7.37 ± 0.44 10.4 ± 1.4 0.057 ± 0.014 
(0.6%) 
N.D.d 
 
1.21 ± 0.09 
(18.9%) 
P3HA31∆maeB 8.40 ± 0.31 7.00 ± 0.47 
 
0.357 ± 0.014 
(5.8%) 
N.D.d 
 
0.67 ± 0.06 
(15.4%) 
P3HA31∆pckA 8.51 ± 0.32 9.7 ± 1.8 0.510 ± 0.018 
(6.0%) 
0.403 ± 0.024 
(6.3%) 
0.89 ± 0.31 
(15.0%) 
P3HA31∆ppc 8.85 ± 0.13 11.6 ± 3.5 0.164 ± 0.007 
(1.6%) 
N.D.d 
 
1.6 ± 0.6 
(22.4%) 
P3HA31∆pykF 8.27 ± 0.50 8.4 ± 2.9 0.56 ± 0.08 
(7.6%) 
0.53 ± 0.11 
(9.5%) 
0.76 ± 0.41 
(14.7%) 
P3HA31∆ppsA 8.82 ± 0.23 8.1 ± 1.1 0.84 ± 0.05 
(12.1%) 
N.D.d 
 
0  
(0%) 
P3HA31∆aceF 11.96 ± 0.06 ~20 0.99 ± 0.07 
(5.7%) 
0.234 ± 0.034 
(1.8%) 
1.06 ± 0.02 
(8.6%) 
P3HA31∆pflB 8.29 ± 0.62 11.6 ± 0.9 0.44 ± 0.11 
(4.3%) 
 0.42 ± 0.1 
(5.5%) 
1.1 ± 0.6 
(14.6%) 
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Figure 7: A graph comparing the production of 3-HB and 3-HV relative to P3HA31 for the 
mutants of genes associated with the PEP-pyruvate node. 
3.6 - Genetic manipulation of global regulator systems 
Four global regulator enzymes (ArcA, Fnr, CreB, and CreC) were examined via gene knockouts 
and the results are shown in Table 9. Also, the relative 3-hydroxy acid productions of these 
knockouts are shown in Figure 8. These regulator systems affect multiple different enzymes and 
pathways depending on environmental conditions such as oxygen and carbon source availability. 
Inactivation of arcA, which encodes for the DNA-binding transcriptional regulator, ArcA, resulted 
in a 3.2-fold increase in 3-HB titer and significant reduction in 3-HV titer compared to P3HA31. 
Cell growth was significantly inhibited in P3HA31∆arcA compared to P3HA31. Another DNA-
binding transcriptional regulator, Fnr (encoded by fnr), was inactivated in P3HA31∆fnr, which 
had a 2.1-fold increase in 3-HB titer and a significantly reduced 3-HV titer compared to P3HA31. 
Cell growth was not significantly affected in P3HA31∆fnr. The CreBC regulator system is a 
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carbon source sensitive, two-component regulator system, where the sensory kinase, CreC, 
(encoded by creC) phosphorylates the DNA-binding transcriptional regulator, CreB, (encoded by 
creB) activating it. The CreBC regulator system is presumed to be inactive in both P3HA31∆creB 
and P3HA31∆creC (Cariss et al., 2008). P3HA31∆creB had similar 3-HB and 3-HV titers to what 
was observed in P3HA31 while P3HA31∆creC increased 3-HB titer by 1.3-fold, with no 
significant 3-HV production. Both P3HA31∆creB and P3HA31∆creC had significantly lower cell 
growth than the P3HA31. 
Table 9: Growth data and metabolite profile of P3HA31 and mutants of genes coding for global 
regulators. 
a 
Measured cell density after 48h cultivation using spectrophotometer (OD600) initial cell densities were kept at ~5.0 
b Consumed acetate after 48h cultivation (20 g/L initial concentration) 
c Metabolites produced after 48h cultivation, yield is presented in parentheses as a percentage of theoretical 
maximum yield based on acetate consumed (%) 
d No 3-HV was detected as the 3-HV peak could not be accurately separated from the acetate peak 
 
Strain Cell 
density 
(OD600)a 
Acetate 
consumed 
(g/L)b 
Metabolites produced (g/L)c 
3-HB  3-HV  Propionate  
P3HA31 
(control) 
9.39 ± 0.63 18.3 ± 1.6 0.562 ± 0.044 
(3.6%) 
0.571 ± 0.053 
(4.8%) 
2.92 ± 0.67 
(25.9%) 
P3HA31∆arcA  7.38 ± 0.11 14.1 ± 1.1 1.75 ± 0.05 
(14.1%) 
0.32 ± 0.04 
(3.5%) 
1.58 ± 0.04 
(18.2%) 
P3HA31∆fnr 8.1 ± 1.1 17 ± 3 1.14 ± 0.11 
(7.6%) 
0.31 ± 0.03 
(2.7%) 
1.13 ± 0.50 
(10.8%) 
P3HA31∆creB 7.71 ± 0.10 6.6 ± 1.3 0.513 ± 0.006 
(8.8%) 
0.49 ± 0.15 
(11.2%) 
0.583 ± 0.039  
(14.3%) 
P3HA31∆creC 7.71 ± 0.34 6.6 ± 1.8 0.757 ± 0.050 
(13.0%) 
N.D.d 
 
0.55 ± 0.17 
(13.4%) 
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Figure 8: A graph comparing the production of 3-HB and 3-HV relative to P3HA31 for the 
mutants of genes coding for global regulators. 
Chapter 4 – Discussion 
 
Cultivation conditions, i.e. temperature and carbon source concentration, were initially studied in 
order to develop a standard procedure for subsequent gene knockout cultivations, while improving 
3-hydroxy acid production and acetate consumption in P3HA31. The effect of temperature was 
observed when P3HA31 was grown at both 30˚C and 37˚C. As shown in Table 4, the 3-HV titer 
was considerably higher at 30˚C compared to 37˚C, while 3-HB titer was also slightly increased 
at 30˚C. Previous experiments concerning propionyl-CoA derived products suggest enhanced 
carbon flux through the Sbm pathway at 30˚C (Miscevic, 2018). This suggestion is also supported 
by the significantly increased propionate titer of P3HA31 at 30˚C compared to 37˚C. Initial acetate 
concentration in the cultivation media was also investigated with the results shown in Table 5. At 
0
50
100
150
200
250
300
350
P3HA31 (control) P3HA31 ∆arcA P3HA31 ∆fnr P3HA31 ∆creB P3HA31 ∆creC
P
ro
d
u
ct
 t
it
er
 r
el
at
iv
e 
P
3
H
A
3
1
 (
%
)
3-HB 3-HV
30 
 
high concentrations (at 30 g/L of acetate), cell growth and acetate consumption were dramatically 
reduced.  The cultivation media is fixed to an initial pH of 7, meaning both protonated acetic acid 
and ionized acetate are present in solution. The protonated acetic acid is lipophilic and can pass 
through the cell membrane then dissociate in the alkaline cytoplasm (pH of ~7.4) decreasing the 
intracellular pH (Luli & Strohl, 1990). To maintain homeostasis within the cells, energy is required 
via the proton motive force to maintain sufficient intracellular pH (Luli & Strohl, 1990). 
Additionally, anionic metabolites such as glutamate must be excreted to exchange for the acetate 
ions in the cytoplasm, in order to maintain electroneutrality across the cell membrane (Roe et al., 
1998). These mechanisms lead to cell growth inhibition in the presence of acetate media, with the 
inhibition effects being exacerbated at higher acetate concentrations. Therefore, the standard 
cultivation conditions were set at 30˚C with 20 g/L acetate media for investigating the effects of 
genetic manipulations. 
Acetate assimilation in E. coli occurs by two distinct pathways, the AckA-Pta pathway, or 
via the Acs enzyme.  The significance of each pathway for acetate assimilation is dependent on 
extracellular acetate concentration. Acs has a high affinity for acetate (KM = 200 µM) and is 
functional under scavenging conditions with low acetate concentrations. The enzymes Pta and 
AckA have comparatively low substrate affinity (KM = 7-10 mM) and are predominantly effective 
for acetate metabolism at high acetate concentrations (Wolfe, 2005). During growth on acetate as 
the sole carbon source, both pathways should be active with AckA-Pta being responsible for initial 
acetate consumption, while Acs becomes more active towards the end of the cultivations when 
acetate concentrations are low. It should be noted the Acs pathway also converts ATP to AMP, 
whereas the AckA-Pta pathway converts ATP to ADP during their production of acetyl-CoA. 
Removing the AckA-Pta pathway activity in P3HA31∆pta did not significantly affect cell growth 
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but did decrease acetate consumption as well as caused negligible metabolite production. This 
could suggest that the Acs pathway can sufficiently assimilate acetate to maintain cell growth but 
requires excessive energy (in the form of ATP to AMP conversion) that metabolite production is 
significantly hindered. This hypothesis of energy dependence is also supported by the slightly 
increased 3-HB production observed in P3HA31Δacs. By removing the Acs pathway function, 
acetate assimilation favors the more energy efficient AckA-Pta pathway, which could lead to the 
increased 3-HB production.    
The glyoxylate shunt pathway is highly active under acetate metabolism (Oh et al., 2002) 
acting as a route to incorporate acetyl-CoA into the TCA cycle, as well as bypassing the carbon 
dioxide producing steps of the TCA cycle. By removing each malate synthase activity in 
P3HA31∆aceB and P3HA31∆glcB individually, no significant effect in 3-HB titer was observed. 
Although the malate synthases are genetically and structurally independent, both are active under 
acetate metabolism (Oh et al., 2002; Pellicer et al., 1999). As a result, when one malate synthase 
is inactivated the other can maintain carbon flux through glyoxylate bypass pathway (Pellicer et 
al., 1999). However, in P3HA31∆aceB∆glcB activity of both malate synthases were removed and 
the mutant produced a significantly increased 3-HB titer. AceB and GlcB each act on acetyl-CoA 
and are competitive with the 3-hydroxy acid pathways. Therefore, when this competitive pathway 
is no longer active in P3HA31∆aceB∆glcB, more carbon flux can be directed towards 3-HB 
production. Conversely, the removal of IclR activity in P3HA31∆iclR would allow increased 
expression of the aceBAK operon resulting in increased carbon flux through the glyoxylate shunt. 
The increased expression of AceB could enhance acetyl-CoA consumption through the glyoxylate 
shunt. This could result in the decrease in 3-HB and 3-HV production observed in P3HA31∆iclR, 
due to the decreased acetyl-CoA pool. 
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The major route for pyruvate production is via the two malate dehydrogenases, the NADH-
producing SfcA and the NADPH-producing MaeB.  P3HA31∆maeB observed decreased 3-HB 
and 3-HV titres, however no significant 3-HB or 3-HV production was observed in P3HA31∆sfcA.  
During growth on acetate NADPH can be generated in excess via, the Icd catalyzed conversion of 
isocitrate to 2-ketoglutarate, whereas NADH is limiting by comparison (Clark & Cronan, 1996). 
This could suggest the apparent requirement of SfcA in order to produce NADH during growth on 
acetate, whereas MaeB is not required for NADPH production. Since 3-hydroxy acid synthesis 
pathways require both NADH and NADPH, the inhibited NADH production in P3HA31∆sfcA 
could drastically decrease 3-hydroxy acid productions. PckA serves as a separate route to the PEP-
pyruvate node from TCA intermediates by catalyzing the production of PEP from OAA. The 
removal of PckA activity in P3HA31∆pckA did not yield a significant change in 3-HB titer and 
only a slight decrease in 3-HV titer. In the absence of PckA, the PEP pool can be maintained via 
the SfcA/MaeB and PpsA pathway under growth on acetate (Oh et al., 2002), suggesting PckA is 
not required for acetate metabolism. Similarly, PckA can provide sufficient PEP production when 
the activity of PpsA is removed. However, it has been shown that deletion of the ppsA gene can 
affect the expression of specific global regulators (Kao et al., 2005), which may have caused the 
apparent inhibition of the Sbm pathway. This could result in the lack of odd-chain metabolite (3-
HV and propionate) production observed for P3HA31ΔppsA. An inactive Sbm pathway would not 
allow any propionyl-CoA production thereby preventing propionate or 3-HV production. The 
absence of propionyl-CoA could also result in increased 3-HB production by removing the 3-HV 
pathway, which is in competition for acetyl-CoA. The removal of Ppc activity resulted in 
significantly decreased production of both 3-hydroxy acids, however propionate production was 
only slightly lower than in P3HA31. Enzyme activity assays of E. coli mutants lacking ppc gene 
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have shown an upregulation of GltA, Icd, AceA, and Mdh enzymes resulting in increased flux 
through the TCA cycle and glyoxylate shunt (Peng & Shimizu 2004). These pathways direct 
carbon flux towards the Sbm pathway while also competing for acetyl-CoA. This could lead to a 
decrease of intracellular acetyl-CoA concentration in ppc deletion mutants (Peng & Shimizu 
2004), which could result in the decreased production of 3-hydroxy acids. P3HA31∆pykF did not 
exhibit any significant change in 3-hydroxy acid titers compared to P3HA31. The results suggest 
PykF is not critical for acetate metabolism, which is supported by the down-regulation of pykF 
during growth on acetate (Oh et al., 2002). Removal of AceEF activity adversely affects the aerobic 
growth of E. coli, however growth can be restored with acetate supplementation (Clark & Cronan, 
1996). Therefore, it’s suggested that AceEF is required for production of acetyl-CoA from 
structurally unrelated carbon sources. In the case of acetate metabolism, acetyl-CoA would be 
directly produced from acetate and the AceEF-mediated conversion from pyruvate forms a futile 
loop.  P3HA31∆aceF breaks this futile loop and prevents the energy and carbon loss associated. 
This in turn allows pyruvate accumulation (Tomar et al., 2003) that could be repurposed towards 
biomass production resulting in the increased cell density in P3HA31∆aceF when compared to 
P3HA31. The carbon and energy conservation associated with breaking the futile loop could also 
contribute to increased production of 3-HB.  Similarly, PflB causes the futile loop converting 
pyruvate to acetyl-CoA under anaerobic growth. However, growth conditions in the shaker are not 
strictly anaerobic resulting in low PflB activity. Due to the low activity of PflB under the shaker 
conditions, P3HA31∆pflB did not significantly affect 3-hydroxy acid titers. 
Global regulators affect gene expression for various pathways making them important 
targets for genetic manipulations. These regulators bind to specific markers of affected genes to 
either inhibit or activate transcription of affected genes to regulate their expression. Removal of 
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either ArcA or Fnr activity, produced significantly higher titers of 3-HB and significantly lower 
titers of 3-HV compared to P3HA31. ArcA is active during the transition of aerobic to micro-
aerobic growth, whereas, Fnr is predominantly active during the transition to anaerobic growth 
(Shalel Levanon et al., 2005).  The results suggest that by removing the activity of these regulators, 
cells would not transition from aerobic growth to microaerobic or anaerobic growth while available 
oxygen in the shaker environment decreased. The continued aerobic growth could cause 
accumulation of the acetyl-CoA pool leading to the increased 3-HB production.  It has also been 
suggested that P3HA31∆arcA mutants possess higher NADH/NAD+ ratios than in wild-type cells 
(Shalel-Levanon et al., 2005). The increased NADH pool could enhance flux through the NADH-
dependent 3-hydroxy acid pathways leading to further increases in the 3-HB titer. The CreBC 
regulator system has been shown to be activated under aerobic growth on acetate (Cariss et al., 
2008). The CreBC regulator system activates the expression of the ackA gene (Avison et al., 2001; 
Godoy et al., 2016). Since AckA is critical in acetate assimilation its decreased expression under 
P3HA31∆creB and P3HA31∆creC mutants would cause the reduced carbon consumption rates 
observed in these mutants. The CreBC regulator system may be involved in the expression of other 
genes related to acetate metabolism allowing acetyl-CoA accumulation despite low acetate 
consumption leading to the unaffected and slightly increased 3-HB titers observed in 
P3HA31∆creB and P3HA31∆creC respectively.  
Chapter 5 – Conclusions 
 
In conclusion, this study has demonstrated that both 3-HB and 3-HV can be effectively produced 
using acetate as a feedstock. Manipulations of culture conditions resulted in increased production 
of 3-HB and 3-HV at 30˚C compared 37˚C. Additionally, inhibition of cell growth and product 
formation was observed when using 30 g/L acetate in the initial media, however this inhibition 
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was not observed when using 20 g/L acetate in the initial media. Genetic manipulations of acetate 
metabolism pathways suggest theories to affect 3-hydroxy acid productions: i) 3-HB production 
appears to be dependant on acetyl-CoA availability as the elimination of non-essential acetyl-CoA-
consuming pathways increased 3-HB titre. Additionally, increases in acetyl-CoA consumption by 
competitive pathways resulted in decreased 3-HB titre ii)  3-HV production appears to require a 
balance of both acetyl-CoA and propionyl-CoA precursors. It is thought that this balance is best 
achieved in the control strain, P3HA31, as all genetic manipulations resulted in a decreased 3-HV 
titer iii) Accumulation and efficient use of reducing equivalents (NADH/NADPH) and energy 
(ATP) are also important for 3-hydroxy acid formation. Further research into production of 3-
hydroxy acids using acetate feedstock could be directed towards gene overexpressions to increase 
acetate assimilation, supplementations to increase intracellular reducing equivalents and/or 
energy, or developing a more acetate-tolerant strain to limit the inhibitory effects at high 
concentrations of acetate.  
Chapter 6 – Future applications of 3-hydroxy acid production using acetate 
 
As mentioned previously, 3-HB and 3-HV can be used as monomers for production of the 
biopolymer, PHBV. Previous studies have demonstrated the production of PHBV using CPC-Sbm 
containing a two-plasmid system for heterologous expression of the PHBV production pathway 
(this strain is referred to as CPC-PHBV) (Srirangan et al., 2016). The authors in this study 
demonstrate a similar metabolic pathway for PHBV production to that which has been discussed 
for 3-hydroxy acid formation (Figure 9).  This pathway relies on the polyhydroxyalkanoate 
polymerase, PhaC (encoded by phaC from C. necator) to fuse 3-HB-CoA and 3-HV-CoA to 
produce PHBV in place of TesB (for 3-hydroxy acid production). Additionally, PhaC is selective 
for only the (R) enantiomer eliminating the need of Hbd for (S) enantiomer production. The authors 
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reported production of 6.8 g/L of PHBV with 7.2mol% 3-HV monomer, using a batch bioreactor 
under semiaerobic aeration conditions with 30 g/L glycerol as the carbon source. Interestingly, the 
authors also reported production of approximately 6 g/L of acetate during cultivation. We 
performed a similar cultivation using CPC-PHBV growing on acetate as the sole carbon source.  
The results for this experiment compared to the previously reported values can be found in Table 
10. We demonstrated that under microaerobic aeration conditions CPC-PHBV can produce 6.4 
g/L of PHBV with 11.7mol% 3-HV monomer using 20 g/L acetate as a carbon source.  These 
results could suggest an opportunity of using the waste acetate from the cell-free bioreactor effluent 
for a secondary cultivation to increase PHBV production. Additionally, results of this thesis project 
could be used to metabolically engineer CPC-PHBV to increase biopolymer production or affect 
the composition of the biopolymer. 
 
 
Figure 9: Heterologous PHBV pathway from acetyl-CoA and propionyl-CoA precursors. Enzyme 
abbreviations: PhaA, acetoacetyl-CoA thiolase (from C. necator); BktB, ß-ketothiolase (from C. 
necator); PhaB, acetoacetyl-CoA reductase (from C. necator); PhaC, polyhydroxyalkanoate 
polymerase (from C. necator). 
                        
                 
          
    
                 
               
                        
          
    
    
    
     
     
          
    
     
     
    
                                            
37 
 
Table 10: Comparison of biopolymer content and composition for PHBV production reported in 
a previous study using glycerol as a carbon source versus experimental PHBV production using 
acetate as a carbon source. 
Study Feedstock Aeration 
condition 
 OD600a Dry cell 
weight 
(g/L) 
Biopolymer 
content 
(g/L) 
3-HV 
content 
(mol%) 
(Srirangan 
et al., 
2016) 
30g/L 
glycerol 
Semiaerobicb   Not 
specified 
11 6.8 7.2 
This study 20 g/L 
acetate 
Microaerobicc  27.3 8.5 ± 0.1 6.40 ± 0.34 11.7 ± 0.1 
a Sample for analysis was taken when all acetate was consumed. 
b Semiaerobic condition achieved by sparging air into the bulk culture at 0.1 vvm 
c Microaerobic condition achieved by purging air into the bioreactor headspace at 0.1 vvm 
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